Excipient Interactions in Glucagon Dry Powder Inhaler Formulation for Pulmonary Delivery

Purpose: This study describes the development and characterization of glucagon dry powder inhaler (DPI) formulation for pulmonary delivery. Lactose monohydrate, as a carrier, and L-leucine and magnesium stearate (MgSt) were used as dispersibility enhancers for this formulation. Methods: Using Fourie...

Descripción completa

Detalles Bibliográficos
Autores principales: Rashid, Md Abdur, Elgied, Amged Awad, Alhamhoom, Yahya, Chan, Enoch, Rintoul, Llew, Allahham, Ayman, Islam, Nazrul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571834/
https://www.ncbi.nlm.nih.gov/pubmed/31052466
http://dx.doi.org/10.3390/pharmaceutics11050207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571834/
https://www.ncbi.nlm.nih.gov/pubmed/31052466
http://dx.doi.org/10.3390/pharmaceutics11050207

Ejemplares similares